HUTCHMED (China) Limited - ADR
HCM
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.94B
Close$
$18.74
68.4% upside
Current Fair Value
68.4% upsideUndervalued by 68.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.94 Billion |
|---|---|
| Enterprise Value | $1.97 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.65 |
| Beta | 0.43 |
| Outstanding Shares | 2,015,463,917 |
Return
| Return on Equity | 36.91% |
|---|---|
| Return on Assets | 26.06% |
| Return on Invested Capital | -2.72% |
Valuation & Multiples
| P/E Ratio | 4.17 |
|---|---|
| PEG | -4.98 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.59 |
| Enterprise Value to EBIT | -50.32 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$0.14
Average shareholder expectationRevenue Estimate
$304.16 M
Average shareholder expectationNext Earnings Call
Expected Date
August 3, 2026
EPS Estimate
$0.15
Average shareholder expectationRevenue Estimate
$306.40 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.49%▲ 2.23% |
|---|---|
| Total Invested | $63.96M▼ 7.47% |
| Investors Holding | 53▲ 5.00% |
ESG Score
No data
About Hutchison China Meditech Ltd.
CEO: Christian Hogg